Nutriband Inc. (NASDAQ:NTRBW – Get Free Report) shares dropped 3% on Wednesday . The company traded as low as $1.60 and last traded at $1.60. Approximately 2,859 shares traded hands during trading, an increase of 9% from the average daily volume of 2,626 shares. The stock had previously closed at $1.65.
Nutriband Stock Down 3.0%
The business has a 50 day moving average of $1.49 and a 200-day moving average of $1.81.
Institutional Trading of Nutriband
A hedge fund recently bought a new stake in Nutriband stock. Clear Street Group Inc. purchased a new position in shares of Nutriband Inc. (NASDAQ:NTRBW – Free Report) during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm purchased 61,590 shares of the company’s stock, valued at approximately $105,000.
About Nutriband
Nutriband Inc develops a portfolio of transdermal pharmaceutical products. Its lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy. The company also develops other products, which include AVERSA buprenorphine and AVERSA methylphenidate; exenatide for type 2 diabetes; and follicle stimulating hormone for infertility.
Further Reading
- Five stocks we like better than Nutriband
- A month before the crash
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
- Wall Street Alert: Buy AES
- Your Bank Account Is No Longer Safe
- Bitcoin is down but your income is about to explode
Receive News & Ratings for Nutriband Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutriband and related companies with MarketBeat.com's FREE daily email newsletter.
